University of Surrey Research Suggests New Treatment Strategy to Tackle Rare Immune Disorders
December 13, 2024
December 13, 2024
GUILFORD, England, Dec. 13 (TNSres) -- The University of Surrey issued the following news release:
Several rare immune disorders are caused by mutations in the patient's DNA. The University of Surrey and its collaborators found that targeting the mutated pathways with new drugs offers new hope for people suffering from rare conditions such as immunodeficiencies.
The multidisciplinary team looked at a genetic mutation called biallelic PI4KA, which impacts B cells in the . . .
Several rare immune disorders are caused by mutations in the patient's DNA. The University of Surrey and its collaborators found that targeting the mutated pathways with new drugs offers new hope for people suffering from rare conditions such as immunodeficiencies.
The multidisciplinary team looked at a genetic mutation called biallelic PI4KA, which impacts B cells in the . . .